Gottlieb AB - Search Results

1

Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3.

van de Kerkhof P, Guenther L, Gottlieb AB, Sebastian M, Wu JJ, Foley P, Morita A, Goldblum O, Zhang L, Erickson J, Ball S, Rich P. van de Kerkhof P, et al. Among authors: gottlieb ab. J Eur Acad Dermatol Venereol. 2017 Mar;31(3):477-482. doi: 10.1111/jdv.14033. Epub 2016 Dec 2. J Eur Acad Dermatol Venereol. 2017. PMID: 27910156 Clinical Trial.

2

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.

Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, Weinstein G. Lebwohl M, et al. J Am Acad Dermatol. 1998 Sep;39(3):464-75. doi: 10.1016/s0190-9622(98)70325-1. J Am Acad Dermatol. 1998. PMID: 9738783 Review.

3

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652

4

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis.

Krueger JG, Walters IB, Miyazawa M, Gilleaudeau P, Hakimi J, Light S, Sherr A, Gottlieb AB. Krueger JG, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2000 Sep;43(3):448-58. doi: 10.1067/mjd.2000.106515. J Am Acad Dermatol. 2000. PMID: 10954656 Clinical Trial.

5

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.

Gottlieb AB, Lebwohl M, Shirin S, Sherr A, Gilleaudeau P, Singer G, Solodkina G, Grossman R, Gisoldi E, Phillips S, Neisler HM, Krueger JG. Gottlieb AB, et al. J Am Acad Dermatol. 2000 Oct;43(4):595-604. doi: 10.1067/mjd.2000.107945. J Am Acad Dermatol. 2000. PMID: 11004613 Clinical Trial.

6

Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial.

Strauss JS, Gottlieb AB, Jones T, Koo JY, Leyden JJ, Lucky A, Pappas AA, McLane J, Leach EE. Strauss JS, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):777-84. doi: 10.1067/mjd.2000.110391. J Am Acad Dermatol. 2000. PMID: 11050580 Clinical Trial.

7

A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB(389)IL-2) in patients with severe psoriasis.

Martin A, Gutierrez E, Muglia J, McDonald CJ, Guzzo C, Gottlieb A, Pappert A, Garland WT, Bagel J, Bacha P. Martin A, et al. J Am Acad Dermatol. 2001 Dec;45(6):871-81. doi: 10.1067/mjd.2001.117852. J Am Acad Dermatol. 2001. PMID: 11712032 Clinical Trial.

8

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.

Gottlieb AB, Evans R, Li S, Dooley LT, Guzzo CA, Baker D, Bala M, Marano CW, Menter A. Gottlieb AB, et al. J Am Acad Dermatol. 2004 Oct;51(4):534-42. doi: 10.1016/j.jaad.2004.02.021. J Am Acad Dermatol. 2004. PMID: 15389187 Clinical Trial.

9

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.

Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, Zaias N, Chen DM, Parneix-Spake A, Hultsch T, Menter A. Gribetz C, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2004 Nov;51(5):731-8. doi: 10.1016/j.jaad.2004.06.010. J Am Acad Dermatol. 2004. PMID: 15523351 Clinical Trial.

10

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB; Efalizumab Study Group. Leonardi CL, et al. Among authors: gottlieb ab. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):425-33. doi: 10.1016/j.jaad.2004.09.029. J Am Acad Dermatol. 2005. PMID: 15761420 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters